Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

Daihan Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	167,286	171,990	154,056	163,170	183,600	172,200
Market Cap Growth	10.06%	11.64%	-5.59%	-11.13%	6.62%	-12.90%
Enterprise Value	77,764	85,789	80,167	60,093	96,028	117,564
Last Close Price	28450.00	29250.00	25333.88	25919.62	27814.69	25531.67
PE Ratio	6.05	6.22	4.56	5.74	7.36	7.60
PS Ratio	0.80	0.82	0.75	0.83	1.00	1.00
PB Ratio	0.56	0.57	0.56	0.66	0.82	0.85
P/TBV Ratio	0.56	0.57	0.56	0.66	0.82	0.85
P/FCF Ratio	347.41	357.17	7.76	9.28	9.01	5.99
P/OCF Ratio	6.53	6.72	4.32	4.20	6.33	4.24
EV/Sales Ratio	0.37	0.41	0.39	0.31	0.52	0.69
EV/EBITDA Ratio	1.92	2.12	1.77	1.35	2.28	2.90
EV/EBIT Ratio	2.49	2.75	2.11	1.68	2.91	4.04
EV/FCF Ratio	161.49	178.16	4.04	3.42	4.71	4.09
Debt / Equity Ratio	0	0	0	-	0.03	0.12
Debt / EBITDA Ratio	0.00	0.00	0.00	-	0.15	0.58
Debt / FCF Ratio	0.03	0.03	0.00	-	0.32	0.82
Net Debt / Equity Ratio	-0.30	-0.30	-0.28	-0.42	-0.40	-0.36
Net Debt / EBITDA Ratio	-2.22	-2.22	-1.70	-2.35	-2.16	-1.80
Net Debt / FCF Ratio	-185.91	-185.91	-3.89	-5.94	-4.47	-2.53
Asset Turnover	0.62	0.62	0.66	0.69	0.67	0.65
Inventory Turnover	4.75	4.75	5.36	5.38	5.46	5.22
Quick Ratio	2.84	2.84	2.58	3.28	3.04	2.72
Current Ratio	3.64	3.64	3.22	3.87	3.65	3.20
Return on Equity (ROE)	9.59%	9.59%	12.89%	12.01%	11.66%	11.79%
Return on Assets (ROA)	5.80%	5.80%	7.69%	7.83%	7.50%	6.91%
Return on Invested Capital (ROIC)	12.45%	12.70%	17.74%	19.93%	18.62%	15.86%
Return on Capital Employed (ROCE)	10.30%	10.30%	13.50%	14.20%	14.10%	12.80%
Earnings Yield	16.52%	16.07%	21.91%	17.42%	13.59%	13.16%
FCF Yield	0.29%	0.28%	12.88%	10.77%	11.10%	16.71%
Payout Ratio	18.79%	18.79%	12.82%	13.20%	8.45%	9.30%
Buyback Yield / Dilution	-	-	-	1.75%	0.25%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.